These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22750263)

  • 1. Response to topical clonazepam in patients with burning mouth syndrome: a clinical study.
    Rodríguez de Rivera Campillo E; López-López J; Chimenos-Küstner E
    Bull Group Int Rech Sci Stomatol Odontol; 2010 May; 49(1):19-29. PubMed ID: 22750263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study on clonazepam in patients with burning mouth syndrome.
    Heckmann SM; Kirchner E; Grushka M; Wichmann MG; Hummel T
    Laryngoscope; 2012 Apr; 122(4):813-6. PubMed ID: 22344742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study.
    Amos K; Yeoh SC; Farah CS
    J Orofac Pain; 2011; 25(2):125-30. PubMed ID: 21528119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of clonazepam mouthwash on the symptomatology of burning mouth syndrome: an open pilot study.
    de Castro LA; Ribeiro-Rotta RF
    Pain Med; 2014 Dec; 15(12):2164-5. PubMed ID: 25287613
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of treatment modalities in burning mouth syndrome.
    Barker KE; Batstone MD; Savage NW
    Aust Dent J; 2009 Dec; 54(4):300-5; quiz 396. PubMed ID: 20415927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical clonazepam in stomatodynia: a randomised placebo-controlled study.
    Gremeau-Richard C; Woda A; Navez ML; Attal N; Bouhassira D; Gagnieu MC; Laluque JF; Picard P; Pionchon P; Tubert S
    Pain; 2004 Mar; 108(1-2):51-7. PubMed ID: 15109507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome.
    Danhauer SC; Miller CS; Rhodus NL; Carlson CR
    J Orofac Pain; 2002; 16(4):305-11. PubMed ID: 12455431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome predictors affecting the efficacy of clonazepam therapy for the management of burning mouth syndrome (BMS).
    Ko JY; Kim MJ; Lee SG; Kho HS
    Arch Gerontol Geriatr; 2012; 55(3):755-61. PubMed ID: 22040716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible therapeutic solution for stomatodynia (burning mouth syndrome).
    Woda A; Navez ML; Picard P; Gremeau C; Pichard-Leandri E
    J Orofac Pain; 1998; 12(4):272-8. PubMed ID: 10425973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome.
    Grushka M; Epstein J; Mott A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Nov; 86(5):557-61. PubMed ID: 9830647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of lycopene-enriched virgin olive oil for treating burning mouth syndrome: a double-blind randomised.
    Cano-Carrillo P; Pons-Fuster A; López-Jornet P
    J Oral Rehabil; 2014 Apr; 41(4):296-305. PubMed ID: 24612248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical Clonazepam Solution for the Management of Burning Mouth Syndrome: A Retrospective Study.
    Kuten-Shorrer M; Treister NS; Stock S; Kelley JM; Ji YD; Woo SB; Lerman MA; Palmason S; Sonis ST; Villa A
    J Oral Facial Pain Headache; 2017 Summer; 31(3):257-263. PubMed ID: 28738111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study.
    Fenelon M; Quinque E; Arrive E; Catros S; Fricain JC
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1505-1511. PubMed ID: 28473243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trials for the treatment of burning mouth syndrome: an evidence-based review of the literature.
    de Moraes M; do Amaral Bezerra BA; da Rocha Neto PC; de Oliveira Soares AC; Pinto LP; de Lisboa Lopes Costa A
    J Oral Pathol Med; 2012 Apr; 41(4):281-7. PubMed ID: 22092585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of acupuncture versus clonazepam in patients with burning mouth syndrome.
    Jurisic Kvesic A; Zavoreo I; Basic Kes V; Vucicevic Boras V; Ciliga D; Gabric D; Vrdoljak DV
    Acupunct Med; 2015 Aug; 33(4):289-92. PubMed ID: 25987645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study.
    Carbone M; Pentenero M; Carrozzo M; Ippolito A; Gandolfo S
    Eur J Pain; 2009 May; 13(5):492-6. PubMed ID: 18675569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effective perospirone augmentation with clonazepam for treatment-resistant burning mouth syndrome: A case report.
    Watanabe M; Takao C; Maeda C; Nayanar G; Tominaga R; Kimura Y; Tu TTH; Nagamine T; Toyofuku A
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):464-467. PubMed ID: 38500267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol.
    Femiano F; Lanza A; Buonaiuto C; Gombos F; Nunziata M; Cuccurullo L; Cirillo N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e22-7. PubMed ID: 18155597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study.
    López-Jornet P; Camacho-Alonso F; Leon-Espinosa S
    J Oral Rehabil; 2009 Jan; 36(1):52-7. PubMed ID: 18976257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burning mouth syndrome after taking clonazepam.
    Culhane NS; Hodle AD
    Ann Pharmacother; 2001; 35(7-8):874-6. PubMed ID: 11485137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.